Suomi -
suomi -
Fimea (Suomen lääkevirasto)
glucos fresenius kabi 300 mg/ml infuusioneste, liuos
fresenius kabi ab - glucose monohydrate - infuusioneste, liuos - 300 mg/ml - hiilihydraatit
Suomi -
suomi -
Fimea (Suomen lääkevirasto)
remodulin 10 mg/ml infuusioneste, liuos
ferrer international, sa - treprostinil sodium - infuusioneste, liuos - 10 mg/ml - treprostiniili
Suomi -
suomi -
Fimea (Suomen lääkevirasto)
treposa 10 mg/ml infuusioneste, liuos
amomed pharma gmbh - treprostinil sodium - infuusioneste, liuos - 10 mg/ml - treprostiniili
Euroopan unioni -
suomi -
EMA (European Medicines Agency)
livogiva
theramex ireland limited - teriparatidi - osteoporoosi - kalsiumin homeostaasi - livogiva is indicated in adults. osteoporoosin hoito postmenopausaalisilla naisilla ja miehillä, joilla on lisääntynyt murtumisriski. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures have been demonstrated. hoito osteoporoosi liittyy pitkäaikaiseen, systeemiseen glukokortikoidihoitoon naisilla ja miehillä on suurempi riski saada murtuma.
Euroopan unioni -
suomi -
EMA (European Medicines Agency)
sondelbay
accord healthcare s.l.u. - teriparatidi - osteoporoosi - kalsiumin homeostaasi - sondelbay is indicated in adults. osteoporoosin hoito postmenopausaalisilla naisilla ja miehillä, joilla on lisääntynyt murtumisriski. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures have been demonstrated. hoito osteoporoosi liittyy pitkäaikaiseen, systeemiseen glukokortikoidihoitoon naisilla ja miehillä on suurempi riski saada murtuma.
Suomi -
suomi -
Fimea (Suomen lääkevirasto)
treprostinil tillomed 10 mg/ml infuusioneste, liuos
tillomed pharma gmbh - treprostinil sodium - infuusioneste, liuos - 10 mg/ml - treprostiniili
Euroopan unioni -
suomi -
EMA (European Medicines Agency)
teriparatide sun
sun pharmaceutical industries europe b.v. - teriparatidi - osteoporosis; osteoporosis, postmenopausal - kalsiumin homeostaasi - teriparatide sun is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.
Euroopan unioni -
suomi -
EMA (European Medicines Agency)
kauliv
strides pharma (cyprus) limited - teriparatidi - osteoporosis; osteoporosis, postmenopausal - kalsiumin homeostaasi - kauliv is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.